Basic Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Jan 28, 2024; 30(4): 367-380
Published online Jan 28, 2024. doi: 10.3748/wjg.v30.i4.367
Figure 7
Figure 7 In vivo studies revealed that amlodipine was able to impede Eca109 tumor xenografts. Initially, 1 × 106 Eca109 cells were subcutaneously implanted into the left hind limb of female BALB/c nude mice. After five days, when tumors reached an approximate size of 50 mm3, the mice were orally administered with amlodipine (13 mg/kg/d) or PBS control vehicle once daily via gavage. Following treatment for fifteen days, the mice were euthanized and their respective tumors were excised for further analysis. A and B: Body weight (A) and the growth curves (B) of tumors were compared between the control group and amlodipine group with significant differences observed at aP < 0.05 vs Control; C: Physical images of tumor xenografts in each group; D: The xenogeneic tumor weights in each group aP < 0.05 vs Control; E: Inhibitory rate of amlodipine on Eca109 xenografts in athymic nude mice aP < 0.05 vs Control.